Tuberculosis mortality and drug resistance among patients under TB treatment before and during COVID-19 in Burundi: a case-control study.

Saved in:
Bibliographic Details
Title: Tuberculosis mortality and drug resistance among patients under TB treatment before and during COVID-19 in Burundi: a case-control study.
Authors: Iradukunda A; Department of Global Health and Population, Takemi Program in International Health, Harvard T.H. Chan School of Public Health, P.O. Box 02144, Boston, MA, USA. arnaudiradukunda5@gmail.com.; Department of Medicine, Kamenge Teaching Hospital, University of Burundi, P.0.Box 1020, Bujumbura, Burundi. arnaudiradukunda5@gmail.com., Getnet F; National Data Management Center for Health, Ethiopian Public Health Institute, P.O. Box 5645, Addis Ababa, Ethiopia., Odjidja EN; Department of Medicine, School of Clinical Sciences, Monash University, Wellington Rd, P.O. Box 3168, Clayton, VIC, Australia.
Source: BMC infectious diseases [BMC Infect Dis] 2025 May 17; Vol. 25 (1), pp. 716. Date of Electronic Publication: 2025 May 17.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1471-2334
DOI:10.1186/s12879-025-11093-0